Skip to main content

Table 4 Immunohistochemical staining scores of serous and mucinous ovarian tumors as benign, borderline, and malignant

From: Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors

 

Serous

Mucinous

Benign

Borderline

Malignant

Benign

Borderline

Malignant

(n = 13)

(n = 9)

(n = 24)

(n = 12)

(n = 7)

(n = 3)

p53*

0a

0 (0–1)b

4 (0–4)b

0

0

1 (0–4)c

p21*

3 (0–4)d,e

4 (1–4)f

4 (1–4)f

0.5 (0–4)

2 (1–4)

2 (2–4)

bax**

0 (0–2)

1 (0–4)

1 (0–6)

0 (0–1)g

0 (0–4)

1 (0–3)

bcl-2**

0 (0–2)

0 (0–4)

0 (0–4)

0

0

0

c-kit**

1 (0–6)

0 (0–4)

0.5 (0–12)

0 (0–4)

0 (0–1)

0

Telomerase*

0 (0–3)

0 (0–2)

0 (0–2)

0

0 (0–3)

1 (0–3)

Metallothionein**

2 (0–6)

4 (1–6)i

6 (0–12)i

0 (0–9)

2 (0–12)j

2 (1–6)

  1. Data were presented as median (min-max). * Nuclear staining score. ** Quick score.
  2. a,e,gP < 0.05 vs. borderline and malignant serous.
  3. b,fP < 0.05 vs. benign and borderline mucinous.
  4. c,iP < 0.05 vs. benign serous and benign mucinous.
  5. d,jP < 0.05 vs. benign mucinous.